Ciro Casanova Macario-rekin lankidetzan egindako argitalpenak (24)

2024

  1. Oxidative Damage and Telomere Length as Markers of Lung Cancer Development among Chronic Obstructive Pulmonary Disease (COPD) Smokers

    Antioxidants, Vol. 13, Núm. 2, pp. 156

2023

  1. Circulating miR-206 and miR-1246 as Markers in the Early Diagnosis of Lung Cancer in Patients with Chronic Obstructive Pulmonary Disease

    International Journal of Molecular Sciences, Vol. 24, Núm. 15

2021

  1. Metformin: Experimental and clinical evidence for a potential role in emphysema treatment

    American Journal of Respiratory and Critical Care Medicine, Vol. 204, Núm. 6, pp. 651-666

  2. Telomere length dynamics over 10-years and related outcomes in patients with COPD

    Respiratory Research, Vol. 22, Núm. 1

2020

  1. Circulating mir-1246 in the progression of chronic obstructive pulmonary disease (Copd) in patients from the bode cohort

    International Journal of COPD, Vol. 15, pp. 2727-2737

2019

  1. Plasma metabolomics and clinical predictors of survival differences in COPD patients

    Respiratory Research, Vol. 20, Núm. 1

2018

  1. Shorter telomeres in non-smoking patients with airflow limitation

    Respiratory Medicine, Vol. 138, pp. 123-128

2017

  1. Erratum: Telomere shortening and accelerated aging in COPD: Findings from the BODE cohort [Respiratory Research. 59, 1, (2017)(18)] DOI: 10.1186/s12931-017-0547-4

    Respiratory Research

  2. Telomere shortening and accelerated aging in COPD: findings from the BODE cohort

    Respiratory research, Vol. 18, Núm. 1, pp. 59

2016

  1. Role of HIF1A, VEGFA and VEGFR2 SNPs in the susceptibility and progression of COPD in a Spanish population

    PLoS ONE, Vol. 11, Núm. 5

2015

  1. IL-8 gene variants are associated with lung function decline and multidimensional BODE index in COPD patients but not with disease susceptibility: A validation study

    COPD: Journal of Chronic Obstructive Pulmonary Disease, Vol. 12, Núm. 1, pp. 55-61

2014

  1. Longitudinal assessment in COPD patients: Multidimensional variability and outcomes

    European Respiratory Journal, Vol. 43, Núm. 3, pp. 745-753

2013

  1. Exploring the impact of screening with low-dose CT on lung cancer mortality in mild to moderate COPD patients: A pilot study

    Respiratory Medicine, Vol. 107, Núm. 5, pp. 702-707

2012

  1. Inflammatory and repair serum biomarker pattern. Association to clinical outcomes in COPD

    Respiratory Research, Vol. 13

2011

  1. Gender differences in plasma biomarker levels in a cohort of COPD patients: A pilot study

    PLoS ONE, Vol. 6, Núm. 1

  2. Lung cancer in patients with chronic obstructive pulmonary disease: Incidence and predicting factors

    American Journal of Respiratory and Critical Care Medicine, Vol. 184, Núm. 8, pp. 913-919

  3. TNFA-863 polymorphism is associated with a reduced risk of Chronic Obstructive Pulmonary Disease: A replication study

    BMC Medical Genetics, Vol. 12

  4. The progression of chronic obstructive pulmonary disease is heterogeneous: The experience of the BODE cohort

    American Journal of Respiratory and Critical Care Medicine, Vol. 184, Núm. 9, pp. 1015-1021

2010

  1. EPOC: inflamación bronquial y sistémica

    Archivos de Bronconeumologia, Vol. 46, Núm. SUPPL. 4, pp. 9-15

  2. Microalbuminuria and hypoxemia in patients with chronic obstructive pulmonary disease

    American Journal of Respiratory and Critical Care Medicine, Vol. 182, Núm. 8, pp. 1004-1010